CLAIRE DIPIERO: Open Payments
NPI 1609205046 · LANHAM, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$883 in 39 payments from 12 companies in 2025. Trend: 2023 $401 · 2024 $219 · 2025 $883
Food & beverage: $883
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $138 |
| PFIZER INC. | 6 | $125 |
| AstraZeneca Pharmaceuticals LP | 5 | $117 |
| E.R. Squibb & Sons, L.L.C. | 5 | $96 |
| Novartis Pharmaceuticals Corporation | 4 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $74 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $73 |
| Amgen Inc. | 3 | $73 |
| AtriCure, Inc. | 1 | $30 |
| BridgeBio Pharma, Inc. | 1 | $25 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, FARXIGA, VYNDAQEL, ELIQUIS, LEQVIO, JARDIANCE, LifeVest, Repatha.
Industry payments across MD — which companies pay providers there.
